SN2 SHORT NOTE 5M ★ High-yield

Describe automation, MALDI-TOF and molecular methods in diagnostic microbiology.

Microbiology · 2nd Professional — Para-Clinical

Automation in Bacteriology

System	Function
Automated blood culture (BacT/alert, BACTEC)	Continuous monitoring for CO2 production by colorimetric or fluorescent sensors, read every few minutes. Flags positives within hours instead of at daily manual inspection, and reduces the incubation period from 7 days to 5
Automated identification and susceptibility (VITEK 2, MicroScan, Phoenix)	Miniaturised biochemical panels and broth microdilution read photometrically; give identification and MICs within 4 to 18 hours, with expert systems flagging implausible or unusual phenotypes
Total laboratory automation	Automated specimen inoculation, incubation with digital plate imaging, and growth detection; reduces manual handling and standardises reading
Automated mycobacterial culture (MGIT)	Liquid culture with fluorescent oxygen-quenching detection; positive in about 2 weeks against 6 to 8 for solid media

Maldi-tof Mass Spectrometry

A single colony is smeared onto a target plate and overlaid with a chemical matrix → A laser pulse ionises the sample — matrix-assisted laser desorption/ionisation → The ions are accelerated down a vacuum flight tube; lighter ions arrive first — time OF flight → The pattern of ribosomal protein masses forms a species-specific fingerprint → This is compared against a reference database → An identification is returned in minutes, at a reagent cost of a few rupees

It has transformed diagnostic bacteriology — replacing days of biochemical testing with a result in minutes, at very low running cost after the instrument is purchased. It identifies bacteria, mycobacteria, yeasts and moulds, and can be applied directly to positive blood culture broth
Its limitations — a high capital cost; performance depends entirely on the database, so under-represented organisms are misidentified; it distinguishes closely related species poorly in some genera (Shigella from E. Coli, and within the viridans streptococci); it requires a pure culture; and it gives NO susceptibility information
It solved the Candida auris problem, which conventional biochemical systems misidentify as other species — a case where the technology made an outbreak visible that had been occurring unrecognised

Molecular Diagnostics

Method	Application
Real-time PCR	Detection and quantification — viral load in HIV, hepatitis B and C and CMV, which guides treatment and monitors response
CBNAAT / Xpert MTB/RIF Ultra	A cartridge-based closed system requiring minimal training; detects M. Tuberculosis and rifampicin resistance in about 2 hours. Deployed nationwide under India's tuberculosis programme and among the most consequential diagnostic advances in Indian public health
Line probe assays	Detect resistance mutations for first- and second-line antitubercular drugs
Multiplex syndromic panels	Simultaneous detection of many pathogens from one specimen — respiratory, gastrointestinal, meningitis-encephalitis and bloodstream panels, in about an hour
Lamp (loop-mediated isothermal amplification)	Amplification at a constant temperature, needing no thermocycler; suited to field and peripheral use
Whole-genome sequencing	Outbreak investigation with far greater discrimination than older typing; resistance gene detection; and phylogenetic tracking, as used through the COVID-19 pandemic
Metagenomic sequencing	Sequences all nucleic acid in a specimen without a prior hypothesis; valuable in culture-negative infection, though costly and difficult to interpret

CLINICAL PEARL

Molecular tests detect nucleic acid, which is not the same as detecting infection. They stay positive after the organism is dead — so a positive result may reflect treated infection, colonisation, or a passenger organism rather than the cause of the illness. They also cannot usually give a full susceptibility profile. Culture remains necessary for phenotypic susceptibility testing and for proving viability, which is why molecular methods have supplemented rather than replaced it.

Point-of-care Testing and Applied Aspects

Rapid point-of-care tests have changed Indian practice more than any laboratory instrument, because they work where there is no laboratory — malaria rapid diagnostic tests, dengue NS1 and IgM, HIV rapid tests, rK39 for kala-azar, hepatitis B surface antigen, syphilis, the cryptococcal antigen lateral flow assay, and rapid antigen tests for influenza and SARS-CoV-2
Their strengths — a result within minutes, no electricity or trained microscopist required, use at the bedside or in the field, and a decision made while the patient is still present
Their limitations — lower sensitivity than laboratory methods, so a negative result often does not exclude the diagnosis; no susceptibility information; variable quality between manufacturers; and dependence on correct storage and technique
Interpret according to pre-test probability — the same test performs quite differently in a high- and a low-prevalence setting, and a positive result in a low-prevalence population is more likely to be false
Rapid diagnostics support stewardship by allowing earlier de-escalation and by ruling infection in or out before broad-spectrum treatment is entrenched — their value lies as much in the antibiotics they prevent as in the diagnoses they make
Technology does not replace the specimen; a MALDI-TOF identification of a contaminant is still a contaminant, and a multiplex panel run on saliva submitted as sputum reports oral flora faster and more expensively than culture would

All questions in Clinical & Diagnostic Microbiology

Every Microbiology chapter →